Curia Expands Cell Line Development Offering with CHOZN Platform
Curia signs license agreement with MilliporeSigma to support production of proteins and antibodies ALBANY, N.Y., June 20, 2023 (GLOBE NEWSWIRE) — Curia, a leading contract research, development and manufacturing organization, today announced it has signed a licensing agreement with MilliporeSigma, the North American Life Sciences Business of Merck KGaA, Darmstadt, Germany, that enables Curia and […]
Continue Reading